These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 5171413

  • 1. In vitro sensitivity to amphotericin B of Cryptococcus neoformans isolated in Thailand.
    Gaew-Im M, Thasnakorn P.
    J Med Assoc Thai; 1971 Jan; 54(6):405-9. PubMed ID: 5171413
    [No Abstract] [Full Text] [Related]

  • 2. Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
    Halkin H, Ravid M, Zulman J, Reichert N.
    Isr J Med Sci; 1974 Sep; 10(9):1148-52. PubMed ID: 4611967
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. 5-Fluorocytosine resistance in clinical isolates of Cryptococcus neoformans.
    Chin CS, Cheong YM, Wong YH.
    Med J Malaysia; 1989 Sep; 44(3):194-8. PubMed ID: 2696871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The combined effect of 5-fluorocytosine and amphotericin B in the therapy of murine cryptococcosis.
    Block ER, Bennett JE.
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):476-80. PubMed ID: 4570039
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Letter: Meningoencephalic cryptococcosis. Presence of filamentous forms. Acquired resistance to 5 fluorocytosine and amphotericin B therapy].
    Cadoz M, Micoud M, Pasquier B, Massot C, Goullier A.
    Nouv Presse Med; 1974 Oct 05; 3(33):2108-9. PubMed ID: 4444954
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Cryptococcus meningitis successfully treated by amphotericin B].
    Kubo Y, Fujii M, Tsutsui J, Shimokawa Y, Okuda K.
    Nihon Rinsho; 1971 May 05; 29(5):1439-42. PubMed ID: 5108764
    [No Abstract] [Full Text] [Related]

  • 15. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
    Pappalardo MC, Szeszs MW, Martins MA, Baceti LB, Bonfietti LX, Purisco SU, Baez AA, Melhem MS.
    Diagn Microbiol Infect Dis; 2009 Jun 05; 64(2):146-51. PubMed ID: 19345042
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G, Kobayashi GS.
    J Infect Dis; 1975 Oct 05; 132(4):489-90. PubMed ID: 1102615
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.